Electropalatography (EPG) activities in Japan and the impact of the COVID-19 pandemic on EPG research and therapy: A report of presentations at the 7th EPG Symposium.

COVID-19 pandemic electropalatography (EPG) phonetics speech science speech therapy

Journal

International journal of language & communication disorders
ISSN: 1460-6984
Titre abrégé: Int J Lang Commun Disord
Pays: United States
ID NLM: 9803709

Informations de publication

Date de publication:
07 2022
Historique:
received: 31 08 2021
accepted: 28 02 2022
pubmed: 22 3 2022
medline: 22 7 2022
entrez: 21 3 2022
Statut: ppublish

Résumé

At the 7th Electropalatography Symposium in Japan, held online on the 24 January 2021, a few speakers were invited to talk about how the COVID-19 pandemic had impacted their research and/or speech therapy that involved the use of electropalatography (EPG) as well as the procedures adopted in order to continue their work in a safe manner. The information on protective measures when using instrumental techniques in speech research and therapy may be useful for colleagues in research and the clinic. The primary aims are: (1) to find out whether there are any published recommendations regarding protective measures for using EPG in research and clinic settings; (2) to discuss the impact of the pandemic and the corresponding restrictions and general protective measures directed (or advised) by local government and professional bodies at each stage of EPG work; and (3) to share experiences in using modified procedures for face-to-face EPG therapy sessions and combined EPG teletherapy. In addition, a brief overview of EPG and a summary of EPG research and clinical activities in Japan presented by one of the symposium organizers at the symposium are included. A review of the literature regarding protective measures recommended for using EPG for speech assessment and treatment or research, supplemented by a discussion of our own experiences. The literature review showed that there are no guidelines regarding protective measures for using EPG, but there is some advice regarding speech recording using microphones. Most published articles related to speech and language therapy (SLT) service during COVID-19 are about telepractice or general clinical guidelines for face-to-face speech therapy sessions. The protective measures for using EPG developed based on the general guidelines recommended by local government and professional bodies (e.g., using visors, transparent acrylic board) were described. Using EPG in telepractice was discussed as well. It has been challenging to continue EPG research and therapy during the pandemic. In order to deal with this crisis, available knowledge regarding infection control and recommendations from local government and professional bodies were applied to design methods and procedures that allowed EPG research and therapy to continue. What is already known on the subject There are general protective measures recommended by local government and professional bodies regarding speech therapy sessions (e.g., using personal protective equipment (PPE), social distancing), but little is known about the measures for using instrumental techniques in speech research and therapy, particularly EPG. The equipment of each instrumental technique is different, so measures that are appropriate for one may not be suitable for others. Hence, specific recommendations are needed for EPG. What this paper adds to existing knowledge This paper provides pointers to information about recommendations regarding protective measures for speech research and therapy, supplemented with suggestions specific to EPG provided by experienced users based on actual experience. What are the potential or actual clinical implications of this work? In evaluating the impact of the COVID-19 pandemic on EPG research and therapy, an analytical approach was taken to break down the steps involved in carrying out those activities, and the challenges we faced and the possible alternatives for completing the tasks were discussed. A similar approach can be applied to evaluate other aspects of speech therapy service.

Sections du résumé

BACKGROUND
At the 7th Electropalatography Symposium in Japan, held online on the 24 January 2021, a few speakers were invited to talk about how the COVID-19 pandemic had impacted their research and/or speech therapy that involved the use of electropalatography (EPG) as well as the procedures adopted in order to continue their work in a safe manner. The information on protective measures when using instrumental techniques in speech research and therapy may be useful for colleagues in research and the clinic.
AIMS
The primary aims are: (1) to find out whether there are any published recommendations regarding protective measures for using EPG in research and clinic settings; (2) to discuss the impact of the pandemic and the corresponding restrictions and general protective measures directed (or advised) by local government and professional bodies at each stage of EPG work; and (3) to share experiences in using modified procedures for face-to-face EPG therapy sessions and combined EPG teletherapy. In addition, a brief overview of EPG and a summary of EPG research and clinical activities in Japan presented by one of the symposium organizers at the symposium are included.
METHODS & PROCEDURES
A review of the literature regarding protective measures recommended for using EPG for speech assessment and treatment or research, supplemented by a discussion of our own experiences.
MAIN CONTRIBUTION
The literature review showed that there are no guidelines regarding protective measures for using EPG, but there is some advice regarding speech recording using microphones. Most published articles related to speech and language therapy (SLT) service during COVID-19 are about telepractice or general clinical guidelines for face-to-face speech therapy sessions. The protective measures for using EPG developed based on the general guidelines recommended by local government and professional bodies (e.g., using visors, transparent acrylic board) were described. Using EPG in telepractice was discussed as well.
CONCLUSIONS
It has been challenging to continue EPG research and therapy during the pandemic. In order to deal with this crisis, available knowledge regarding infection control and recommendations from local government and professional bodies were applied to design methods and procedures that allowed EPG research and therapy to continue.
WHAT THIS PAPER ADDS
What is already known on the subject There are general protective measures recommended by local government and professional bodies regarding speech therapy sessions (e.g., using personal protective equipment (PPE), social distancing), but little is known about the measures for using instrumental techniques in speech research and therapy, particularly EPG. The equipment of each instrumental technique is different, so measures that are appropriate for one may not be suitable for others. Hence, specific recommendations are needed for EPG. What this paper adds to existing knowledge This paper provides pointers to information about recommendations regarding protective measures for speech research and therapy, supplemented with suggestions specific to EPG provided by experienced users based on actual experience. What are the potential or actual clinical implications of this work? In evaluating the impact of the COVID-19 pandemic on EPG research and therapy, an analytical approach was taken to break down the steps involved in carrying out those activities, and the challenges we faced and the possible alternatives for completing the tasks were discussed. A similar approach can be applied to evaluate other aspects of speech therapy service.

Identifiants

pubmed: 35307940
doi: 10.1111/1460-6984.12720
pmc: PMC9111328
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

906-917

Informations de copyright

© 2022 The Authors. International Journal of Language & Communication Disorders published by John Wiley & Sons Ltd on behalf of Royal College of Speech and Language Therapists.

Références

Eur Arch Otorhinolaryngol. 2021 May;278(5):1687-1692
pubmed: 32676677
PLoS One. 2020 Jan 27;15(1):e0227699
pubmed: 31986165
J Oral Rehabil. 2017 Sep;44(9):673-682
pubmed: 28581686
Sci Rep. 2019 Feb 20;9(1):2348
pubmed: 30787335
Clin Linguist Phon. 2022 Jun 2;:1-21
pubmed: 35652593
Am J Speech Lang Pathol. 2006 May;15(2):192-206
pubmed: 16782690
Semin Speech Lang. 2015 Nov;36(4):271-82
pubmed: 26458202
Br J Disord Commun. 1991 Apr;26(1):41-74
pubmed: 1954115
J Voice. 2021 Sep;35(5):717-727
pubmed: 32878736
PLoS One. 2021 Apr 28;16(4):e0250308
pubmed: 33909654
Clin Linguist Phon. 2022 Mar 4;36(2-3):102-110
pubmed: 33890543
Mil Med Res. 2020 Feb 6;7(1):4
pubmed: 32029004
Int J Lang Commun Disord. 1998;33 Suppl:44-9
pubmed: 10343662
Am J Speech Lang Pathol. 2020 Nov 12;29(4):1850-1865
pubmed: 32692584
IEEE Open J Eng Med Biol. 2020 May 29;1:203-206
pubmed: 35402959
Int J Lang Commun Disord. 2022 Jul;57(4):906-917
pubmed: 35307940
Int J Speech Lang Pathol. 2020 Feb;22(1):70-77
pubmed: 31014123
Aerosol Sci Technol. 2020 Apr 03;0(0):1-4
pubmed: 32308568
Am J Speech Lang Pathol. 2021 Jan 27;30(1):63-74
pubmed: 33332145
Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25237-25245
pubmed: 32978297
J Laryngol Otol. 2020 Jul;134(7):577-581
pubmed: 32641175
Clin Linguist Phon. 2004 Jun-Aug;18(4-5):285-311
pubmed: 15259573
J Voice. 2021 Sep;35(5):765-771
pubmed: 32753296
J Acoust Soc Am. 2020 Oct;148(4):2371
pubmed: 33138498

Auteurs

Alice Lee (A)

Department of Speech and Hearing Sciences, University College Cork, Cork, Ireland.

Yuri Fujiwara (Y)

Department of Speech Therapy, Osaka Health Science University, Osaka, Japan.

Marko Liker (M)

Department of Phonetics, University of Zagreb, Zagreb, Croatia.

Ichiro Yamamoto (I)

EPG Research Centre, Yamamoto Dental Clinic, Nishinomiya, Japan.

Yoshiko Takei (Y)

Department of Rehabilitation, Showa University, Shinagawa-ku, Japan.

Fiona Gibbon (F)

Department of Speech and Hearing Sciences, University College Cork, Cork, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH